NYSE:PENMedical Equipment
Penumbra (PEN) Earnings Surge Challenges Concerns Over Rich 75x P/E Valuation
Penumbra (PEN) has wrapped up FY 2025 with fourth quarter revenue of US$385.4 million and basic EPS of US$1.21, set against very large reported earnings growth over the past year and a trailing net margin of 12.7%. The company has seen quarterly revenue move from US$315.5 million in Q4 2024 to US$385.4 million in Q4 2025, while basic EPS stepped from US$0.88 to US$1.21 over the same period. On a trailing 12 month basis, revenue reached about US$1.4 billion with basic EPS of US$4.57. With...

